➡️ Read more and find our position papers here: idf.org/europe/news/...

To support our Member Associations, we have also developed a two-page document summarising:

👉 How CGMs are currently assessed in the EU
👉 The main challenges in the current regulatory system
👉 How to report adverse events to national authorities
👉 What key figures high-quality CGMs should meet

3/3

📣 IDF Europe has been calling for amendments to the EU Medical Devices Regulation (MDR) to strengthen oversight and create clear, EU-wide standards for CGMs, including through our response to the revision of the EU rules for Medical Devices and In Vitro Diagnostics.

2/3

🙌 Join our call to action and become part of a powerful and united voice advocating for stronger action on diabetes.

👉 Visit our website to learn more and endorse the Declaration: idf.org/europe/what-...

4/4

📣 On this anniversary, we renew our call on governing bodies to turn their commitments into concrete policy action to ensure that all people living with diabetes, and those at risk, have access to the care they need to lead healthy, long and fulfilling lives.

3/4

⚠️Today, progress towards global targets on #diabetes and #NCDs has stalled. In Europe, only 10 Member States have achieved a 25% reduction in premature mortality from major NCDs and 66 million people live with diabetes, a number projected to reach 72 million by 2050.

2/4